Literature DB >> 11923555

Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRbeta chain conformation.

J Grunewald1, J Wahlström, M Berlin, H Wigzell, A Eklund, O Olerup.   

Abstract

BACKGROUND: Sarcoidosis is a systemic disease of unknown aetiology frequently affecting the lungs. CD4+ T cells, in particular, accumulate in the lungs, implicating them in the pathogenesis of the disease.
METHODS: T cell receptor (TCR) variable (V) gene expression on bronchoalveolar lavage (BAL) fluid T cells and the HLA DR alleles of 121 Scandinavian patients with sarcoidosis was determined.
RESULTS: As expected from our previous results, almost every DRB1*0301 (i.e. DR17) positive patient (67/69) had significantly increased numbers of AV2S3+ CD4+ T cells in the BAL fluid but normal levels in peripheral blood (that is, lung restricted expansions) compared with only six of 52 DRB1*0301 negative patients. Detailed genotypic HLA analysis showed that these six DRB1*0301 negative patients with lung restricted AV2S3+ T cell expansions had another HLA allele in common-the HLA-DRB3*0101 allele (also called DR52a)-which was not found in any other DRB1*0301 negative patient. A new group of sarcoidosis patients was therefore identified, characterised by a strict correlation between a distinct HLA allele and lung accumulated T cells expressing a particular TCR V segment. Furthermore, the HLA-DRB1*0301 and HLA-DRB3*0101 encoded molecules showed similarities, with identical amino acid sequences in regions important for antigen binding which may enable them to bind and present the same or similar antigenic peptides.
CONCLUSIONS: HLA-DRB3*0101 as well as DRB1*0301 positive sarcoidosis patients may have the capacity to present specific sarcoidosis associated antigens in such a way that AV2S3+ CD4+ T cells are stimulated preferentially, generating lung restricted AV2S3+ T cell expansions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923555      PMCID: PMC1746294          DOI: 10.1136/thorax.57.4.348

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  28 in total

1.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

Authors:  O Olerup; H Zetterquist
Journal:  Tissue Antigens       Date:  1992-05

2.  Biased expression of individual T cell receptor V gene segments in CD4+ and CD8+ human peripheral blood T lymphocytes.

Authors:  J Grunewald; C H Janson; H Wigzell
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

3.  Transmission of sarcoidosis via cardiac transplantation.

Authors:  W M Burke; A Keogh; P J Maloney; W Delprado; D H Bryant; P Spratt
Journal:  Lancet       Date:  1990 Dec 22-29       Impact factor: 79.321

4.  Epidemiology of sarcoidosis in the Isle of Man--2: Evidence for space-time clustering.

Authors:  S E Hills; S A Parkes; S B Baker
Journal:  Thorax       Date:  1987-06       Impact factor: 9.139

5.  T cell receptor and peptide-contacting residues in the HLA-DR17(3) beta 1 chain.

Authors:  A Geluk; X T Fu; K E van Meijgaarden; Y Y Jansen; R R De Vries; R W Karr; T H Ottenhoff
Journal:  Eur J Immunol       Date:  1994-12       Impact factor: 5.532

6.  Epidemiology of sarcoidosis in the Isle of Man--1: A case controlled study.

Authors:  S A Parkes; S B Baker; R E Bourdillon; C R Murray; M Rakshit
Journal:  Thorax       Date:  1987-06       Impact factor: 9.139

7.  T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients.

Authors:  J Grunewald; O Olerup; U Persson; M B Ohrn; H Wigzell; A Eklund
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  Sarcoidosis in nurses: is there an association?

Authors:  W M Edmondstone
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

9.  Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution.

Authors:  R E Bontrop; D G Elferink; N Otting; M Jonker; R R de Vries
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

10.  T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type.

Authors:  B Gulwani-Akolkar; D N Posnett; C H Janson; J Grunewald; H Wigzell; P Akolkar; P K Gregersen; J Silver
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

View more
  21 in total

Review 1.  Gene-environment interactions in sarcoidosis: challenge and opportunity.

Authors:  Daniel A Culver; Lee S Newman; Mani S Kavuru
Journal:  Clin Dermatol       Date:  2007 May-Jun       Impact factor: 3.541

2.  Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients.

Authors:  Johan Grunewald; Boel Brynedal; Pernilla Darlington; Magnus Nisell; Kerstin Cederlund; Jan Hillert; Anders Eklund
Journal:  Respir Res       Date:  2010-02-26

3.  Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

Authors:  Hiroe Sato; Felix A Woodhead; Tariq Ahmad; Jan C Grutters; Paolo Spagnolo; Jules M M van den Bosch; Lisa A Maier; Lee S Newman; Sonoko Nagai; Takateru Izumi; Athol U Wells; Roland M du Bois; Kenneth I Welsh
Journal:  Hum Mol Genet       Date:  2010-08-03       Impact factor: 6.150

4.  Shared αβ TCR Usage in Lungs of Sarcoidosis Patients with Löfgren's Syndrome.

Authors:  Angela M Mitchell; Ylva Kaiser; Michael T Falta; Daniel J Munson; Laurie G Landry; Anders Eklund; Maki Nakayama; Jill E Slansky; Johan Grunewald; Andrew P Fontenot
Journal:  J Immunol       Date:  2017-08-21       Impact factor: 5.422

Review 5.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

6.  Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL.

Authors:  Kyra A Oswald-Richter; Dia C Beachboard; Erin H Seeley; Susamma Abraham; Bryan E Shepherd; Cathy A Jenkins; Daniel A Culver; Richard M Caprioli; Wonder P Drake
Journal:  J Clin Immunol       Date:  2012-05-03       Impact factor: 8.317

7.  Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis.

Authors:  Kyra A Oswald-Richter; Dia C Beachboard; Xiaoyan Zhan; Christa F Gaskill; Susamma Abraham; Cathy Jenkins; Daniel A Culver; Wonder Drake
Journal:  Respir Res       Date:  2010-11-23

8.  Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Löfgren's syndrome.

Authors:  M Ostadkarampour; A Eklund; D Moller; P Glader; C Olgart Höglund; A Lindén; J Grunewald; J Wahlström
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

9.  Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis.

Authors:  F Idali; J Wahlström; C Müller-Suur; A Eklund; J Grunewald
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

10.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

Authors:  Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.